AbbVie Inc. (ABBV34.SA)
São Paulo - São Paulo Delayed price. Currency in BRL
Add to watchlist
At close: 04:25PM BRT
| Previous close | 55.40 |
| Open | 56.00 |
| Bid | 55.50 x 0 |
| Ask | 56.96 x 0 |
| Day's range | 56.00 - 56.28 |
| 52-week range | 39.68 - 57.77 |
| Volume | |
| Avg. volume | 5,827 |
| Market cap | 1.59T |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | 51.16 |
| EPS (TTM) | 1.10 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | 1.46 (2.59%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
ZacksPharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Eli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
ZacksAbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Insider MonkeyIs AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts?
We recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since AbbVie Inc. (NYSE:ABBV) is part of our list, we have analyzed the stock in detail. The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm. Between these two, dividend growth is currently […]
© 2024 Yahoo. All rights reserved.